CHRISTOPHER D. OZEROFF

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oruka Therapeutics, Inc.

Filing Date Source Excerpt
2013-02-01 Christopher D. Ozeroff (5) - Beneficial ownership details provided, no mention of software or technical skills.
2018-09-20 Christopher D. Ozeroff is Secretary, Senior Vice President and General Counsel, with no indication of software or technical programming skills.

Data sourced from SEC filings. Last updated: 2025-10-12